Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.14M Buy
85,759
+1,921
+2% +$29.8K ﹤0.01% 2186
2023
Q4
$1.59M Buy
83,838
+8,122
+11% +$133K ﹤0.01% 2032
2023
Q3
$1.14M Sell
75,716
-2,164
-3% -$40.6K ﹤0.01% 2221
2023
Q2
$1.68M Buy
77,880
+25,487
+49% +$695K ﹤0.01% 2037
2023
Q1
$1.47M Buy
52,393
+813
+2% +$23.1K ﹤0.01% 2061
2022
Q4
$1.3M Sell
51,580
-12,806
-20% -$391K ﹤0.01% 2151
2022
Q3
$1.85M Buy
64,386
+1,049
+2% +$31.1K ﹤0.01% 1901
2022
Q2
$1.6M Buy
+63,337
New +$1.83M ﹤0.01% 2061

Other funds holding EMBC

Credit Suisse's EMBC Position: Q1 2024 in Review

Credit Suisse increased its Embecta (EMBC) stake by 2.3% in Q1 2024, buying an estimated $29.8K and bringing the position to 85,759 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2186.

Credit Suisse first reported a position in EMBC in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.85M in Q3 2022. 371 funds tracked by Wall St. Rank hold EMBC as of Q1 2024.

  • Credit Suisse held 85,759 shares of Embecta worth $1.14M as of Q1 2024.
  • Credit Suisse bought 1,921 Embecta shares in Q1 2024, an estimated $29.8K.
  • Embecta made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2186 holding.
  • Credit Suisse first reported a position in Embecta in Q2 2022 and has held it in 8 quarters since.
  • Credit Suisse's Embecta position peaked at $1.85M in Q3 2022.
  • 371 funds tracked by Wall St. Rank held Embecta as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.